The impact of acute phase response on the plasma clearance of antipyrine, theophylline, phenytoin and nifedipine in rabbits

Journal of Veterinary Pharmacology and Therapeutics

Volumn 23, Issue 3, 2000, Pages 153-158

  Saitoh, T ^a,b   Kokue, E ^a   Shimoda, M ^a  

^a TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

^b NIPPON INSTITUTE FOR BIOLOGICAL SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; NIFEDIPINE; PHENAZONE; PHENYTOIN; THEOPHYLLINE;

ACUTE PHASE RESPONSE; ANIMAL EXPERIMENT; ARTICLE; DRUG CLEARANCE; ENZYME INHIBITION; FEMALE; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ACUTE-PHASE REACTION; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTICONVULSANTS; ANTIPYRINE; AREA UNDER CURVE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ESCHERICHIA COLI; FEMALE; HALF-LIFE; INJECTIONS, INTRAMUSCULAR; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; METABOLIC CLEARANCE RATE; NIFEDIPINE; PHENYTOIN; PROTEIN BINDING; RABBITS; THEOPHYLLINE; VASODILATOR AGENTS;

ANIMALIA; ESCHERICHIA COLI; ORYCTOLAGUS CUNICULUS;

EID: 0033757408     PISSN: 01407783     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2885.2000.00266.x     Document Type: Article

References (32)

1. Cytokines downregulate expression of major cytochrome P-450 enzymes in adult human hepatocytes in primary culture
2. Effect of nifedipine on the elimination of theophylline in the rabbit subjected to hypoxia or to an inflammatory reaction
3. Altered theophylline pharmacokinetics during an acute respiratory viral illness
4. Effects of interleukin-6 on cytochrome P450-dependent mixed-function oxidases in the rat
5. Antipyrine as a probe for human oxidative drug metabolism: Identification of the cytochrome P450 enzymes catalyzing 4-hydroxy-antipyrine, 3-hydroxymethylantipyrine, and norantipyrine formation
6. The acute phase response of the liver in inflammation
7. Sensitive high-performance liquid chromatographic assay for nifedipine in human plasma utilizing ultraviolet detection
8. Kinetic analysis of phenytoin disposition in rats with experimental renal and hepatic diseases
9. Nifedipine: Kinetics and hemodynamic effects in patients with liver cirrhosis after intravenous and oral administration
10. The phenomenon of the acute phase response
11. Effect of acute phase response on phenytoin metabolism in neurotrauma patients
12. The effect of the acute-phase response on in vitro drug metabolism and plasma protein binding in the horse
13. Selective effects of a bacterial infection (Actinobacillus pleuropneumoniae) on the hepatic clearances of caffeine, antipyrine, paracetamol, and indocyanine green in the pig
14. A lipopolysaccharide-induced acute phase response in the pig is associated with a decrease in hepatic cytochrome P450-mediated drug metabolism
15. Suppression of constitutive cytochrome P450 gene expression in livers of rats undergoing an acute phase response to endotoxin
16. Down-regulation of multiple cytochrome P450 gene products by inflammatory mediators in vivo
17. Inflammation-induced decrease in hepatic cytochrome P450 in conscious rabbits is accompanied by an increase in hepatic oxidative stress
18. Decreased elimination of theophylline after influenza vaccination
19. The suppressive effects of lipopolysaccharide-induced acute phase response on hepatic cytochrome P450-dependent drug metabolism in rabbits
20. Endotoxemia in rats is associated with induction of the P4504A subfamily and suppression of several other forms of cytochrome P450
21. Endotoxin administration to humans inhibits hepatic cytochrome P450-mediated drug metabolism
22. Endotoxin depresses hepatic cytochrome P450-mediated drug metabolism in women
23. Antipyrine clearance in pneumonia
24. Changes in the metabolism of three model substrates catalyzed by different P450 isozymes when administered as a cocktail to the carbon tetrachloride-intoxicated rat
25. Clinical importance of non-genetic and genetic cytochrome P450 function tests in liver disease
26. Automated high-performance liquid chromatographic determination of antipyrine and its main metabolites in plasma, saliva and urine including 4.4-dihydroxyantipyrine
27. Acute phase response and non cellular defense mechanisms
28. Pro-inflammatory cytokines in a ruminant model: Pathophysiological, pharmacological, and therapeutic aspects
29. Changes in theophylline clearance during acute illness
30. Regulation of cytochrome P450IIC12 expression by interleukin-1α, interleukin-6, and dexamethasone
31. A pharmacokinetic analysis program (MULTI) for microcomputer